国产成人精品日本亚洲999,99久久久国产精品免费蜜臀 ,v一区无码内射国产,被调教的少妇雅芳1一19,国产成人a亚洲精v品无码

更新于 11月5日

臨床QC經(jīng)理

面議
  • 南京江寧區(qū)
  • 10年以上
  • 本科
  • 全職
  • 招1人

職位描述

臨床質(zhì)控
Major Responsibilities
1.Assist to build up and maintain the training system and procedures of China Clinical Operations according to the company policy and Local SOPs. The training system is mainly for providing trainings to Clinical Operations team members. Set up the training procedures and guarantee the procedures are well conducted.
2.Facilitate and support quality and risk management activities in clinical trails (at study level and site level).
?Assist to conduct quality oversight activity and identify quality improvement actions (e.g. corrections and CAPA) based on the results; for example, execute and document quality oversight visits at the Clinical Investigator sites.
?Monitor compliance risks to evaluate if all defined Quality System processes are effectively deployed and continually kept up at study level.
?Help to educate, guide and influence clinical research management and staff on best quality and compliance practices.
?Assist to quality related procedures as assigned.
?Provide consultation and inputs for process improvement in terms of quality oversight and quality review activities.
?Support clinical operation head with the execution of assigned clinical quality responsibilities.
?Lead the team create annual ASV/TMF QC plan and conductions, as well as the following issue tracking/CAPA mechanism.
3.Design and deliver the quality related (GCP) training program in collaboration with key business partners to ensure all staff are clear about the quality expectation and standard of processes, industry and regulatory;
4.Maintain knowledge of latest Regulatory Intelligence and Industry initiatives on clinical research;
5.Drive Continuous Clinical Trail Quality Improvement
?Be an expert in corrective and preventive actions (CAPA) management.
?Lead and collaborate with the business partners in timely developing robust CAPA/risk mitigations.
?Monitor the progress of CAPA & risk mitigations along with the implementations and confirm effectiveness of these actions, e.g. by performing QC checks or special investigations.
?Identify potential gaps or opportunities for improvement and recommendations to improve the QMS (i.e. effectiveness of CAPAs, proactive identification of quality issues, appropriate metrics for QMS health etc.).
?Assist to generate and/or provide metrics, status and trend reports and other information, as required by management.
?Cooperate with team leaders of Clinical operations to develop or update SOPs of China Clinical Operations under the consideration of business requirements and regulations.
6.Support AD of Clinical Trial Quality & Training with the execution of assigned clinical quality and training responsibilities.
Qualifications
1.Job Required Competencies
?Knowledge of the overall drug development process
?Ability to motivate professional colleagues and stakeholders
?Conflict resolution/management and negotiation skills
?Ability to independently plan, organize, coordinate, manage and execute assigned tasks
?Experience of the key customers’ business processes and practices
?Excellent working knowledge of FDA/ICH and country-specific regulations and guidelines related to clinical development
2.Education / Qualifications
?Minimum bachelor’s degree in medical pharmacology or Life/Biological Sciences, advanced degree preferred
?Experience in clinical research (min. 8 years) & quality management/ quality control /Training (min. 2 years).
?Experience in risk assessment and mitigation planning.

工作地點

南京江寧區(qū)傳奇生物月華園區(qū)

職位發(fā)布者

劉先生/招聘主管

三日內(nèi)活躍
立即溝通
公司Logo南京傳奇生物科技有限公司
關(guān)于傳奇生物傳奇生物(NASDAQ: LEGN)是一家處于臨床階段的全球生物制藥公司,成立于2014年,并于美國時間2020年6月5日在納斯達克掛牌上市,成為國內(nèi)第一家CART療法上市公司。傳奇生物專注于腫瘤和其他領(lǐng)域的新型細胞療法的開發(fā)。目前在全球免疫細胞療法領(lǐng)域位列第一方陣,和合作伙伴Janssen將最領(lǐng)先的產(chǎn)品LCAR-B38M細胞制劑已推進至在美國、歐洲藥品上市審評階段,有望解決多發(fā)性骨髓瘤治療的世界級難題。與此同時,傳奇生物還有多款在研CAR-T療法,用于血液瘤、實體瘤及其它疑難疾病的治療。目前,傳奇生物在美國、中國和歐洲已擁有1000余名員工,以差異化技術(shù)、全球化研發(fā)網(wǎng)絡(luò)和專業(yè)的生產(chǎn)策略為有力支撐,為患者提供發(fā)現(xiàn)、開發(fā)和制造一流的細胞療法創(chuàng)造了可能。公司已入選江蘇省戰(zhàn)略性新興產(chǎn)業(yè)發(fā)展專項資金項目,江蘇省精準(zhǔn)細胞免疫治療工程技術(shù)研究中心,榮獲江蘇省科技進步獎、“中國生物醫(yī)藥產(chǎn)業(yè)鏈創(chuàng)新風(fēng)云榜”并獲“鯤鵬獎”,入選“2020中國獨角獸”、“中國醫(yī)藥創(chuàng)新企業(yè)100強”。
公司主頁